Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of FRAIL and FIND Frailty Scales in Predicting Chemotherapy-Related Toxicity Among Older Adults Receiving Adjuvant Treatment for Gastrointestinal Cancers: A Prospective Observational Study

NCT07272538 is registered in ClinicalTrials.gov with Ankara Etlik City Hospital as lead sponsor.

NCT NCT07272538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07272538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of FRAIL and FIND Frailty Scales in Predicting Chemotherapy-Related Toxicity Among Older Adults Receiving Adjuvant Treatment for Gastrointestinal Cancers: A Prospective Observational Study
Lead sponsor
Ankara Etlik City Hospital
Phase
Observational
Overall status
Completed
Start date
December 20, 2023
Completion date
December 20, 2024
Enrollment
84 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy, frailty at older adults, gastrointestinal cancers